Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma
Recent news which mentions Pharma
Why Is Bone Biologics Stock Surging On Friday?
June 27, 2025
Tickers
BBLG
NEWS
Tags
Financing
Trading Ideas
Offerings
From
Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
June 25, 2025
Tickers
LLY
NEWS
VKTX
Tags
Analyst Color
Biotech
VKTX
From
Benzinga
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
June 24, 2025
Tickers
AMGN
NEWS
Tags
Diabetes
pharma
News
From
Benzinga
Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'
June 24, 2025
Tickers
HIMS
QQQ
SPY
Tags
pharma
Weight Loss
Wegpvy
From
Benzinga
Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing
June 21, 2025
Tickers
CVS
JNJ
NEWS
Tags
Donald Trump Jr
Benzinga
Politics
From
Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
June 20, 2025
Tickers
ABBV
AMGN
CI
CVS
Tags
FTXH
UNH
PILL
From
Benzinga
Insmed Shares Skyrocket Following Strong TPIP Phase 2b Data
June 10, 2025
Tickers
INSM
NEWS
Tags
pharma
33
Stocks
From
Wall Street Pit
Phathom Soars 95% on FDA Exclusivity for VOQUEZNA
June 06, 2025
Tickers
NEWS
PHAT
Tags
Stocks
News
PHAT
From
Wall Street Pit
Bill Ackman Slams Subsidies For Contributing To $37 Trillion National Debt, Hails Trump's Drug Price Order
May 12, 2025
Tickers
NEWS
QQQ
SPY
Tags
Donald Trump
Broad U/S/ Equity ETFs
News
From
Benzinga
Ending Big Pharma’s Grip: U.S. Drug Prices Set to Plummet by 80%
May 11, 2025
Tickers
NEWS
Tags
33
pharma
News
From
Wall Street Pit
First Choice Neurology Partners with NeuroDiscovery AI to Advance Neurological Care and Research
May 01, 2025
Tags
Dr/ Bernard Gran
Neurologist
NeuroDiscovery AI
From
PRLog
Roche's $50 Billion US Investment Commitment Includes New Facilities, 12,000 Jobs, Expanded R&D Hubs As Drug Tariffs Loom
April 22, 2025
Tickers
RHHBY
Tags
Donald Trump
General
Health Care
From
Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
Tickers
ABBV
AMGN
BMY
FTXH
Tags
REGN
tariffs
Markets
From
Benzinga
Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches
December 17, 2024
Tags
Chicago
Biotech
Rare Diseases
From
PRLog
Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%
November 28, 2024
Tickers
IPSC
Tags
pharma
Equities
Market News
From
Benzinga
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
November 06, 2024
Tickers
MDMA
NEWS
Tags
MDMA
Market News
Media
From
Benzinga
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
April 30, 2024
Tickers
AAUKF
BLK
COPX
D
Tags
transportation
Mid Cap
IHE
From
Benzinga
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
April 02, 2024
Tickers
MRNA
MYNZ
NEWS
PFE
Tags
News
PFE
contributors
From
Benzinga
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
February 27, 2024
Tickers
BSX
DHR
KRTX
LLY
Tags
Analyst Color
Biotech
Hedge Funds
From
Benzinga
2024 Marks a New Era Of Pharmaceutical Innovation
January 09, 2024
Tickers
MRK
MRNA
MYNZ
NEWS
Tags
Covid/19
Market News
MYNZ
From
Benzinga
Cannabis Based Pain Relief Solution Receives European Patent Approval
October 20, 2023
Tickers
IGC
Tags
General
pain releif
News
From
Benzinga
Johnson & Johnson Lost Its Court Battle But Won The Q2 Match
July 24, 2023
Tickers
JNJ
UNH
Tags
UNH
pharma
Market News
From
Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
June 20, 2023
Tickers
ALS
ALT
BIIB
CYTK
Tags
respiratory
Tech
Benzinga
From
Benzinga
This 12% Dividend Yield Stock Is Set For Payout On Tuesday: What Else To Watch Out For
March 07, 2023
Tickers
FLNG
JNJ
LNG
PROV
Tags
Benzinga
LNG
Dividends
From
Benzinga
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
December 28, 2022
Tickers
CRO
Tags
Information technology
Artificial Intelligence
Molecular Laboratory
From
PRLog
The Surprising Carbon Impact of Science: Study by My Green Lab Finds 91% of Biotech & Pharma Companies Not Aligned With Paris Climate Agreement
November 10, 2022
Tags
My Green Lab
pharma
biotech
From
3BL Media: Corporate Social Responsibility, Energy and Health News
MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF
February 23, 2022
Tickers
DMF
MEDIF
Tags
DMF
Markets
News
From
Benzinga
aiaTranslations Receives ISO 17100 Certification
February 17, 2022
Tags
Translations
Health
Marketing
From
PRLog
Life Sciences Voice Releases Its Much Awaited List of Top Industry Leaders 2021
January 27, 2022
Tags
drug discovery
pharma
biotech
From
PRUnderground
New Study by My Green Lab Finds That Just 4% of Biotech & Pharma Companies Currently on Track to Meet Paris 2030 Climate Goals
November 04, 2021
Tags
green labs
Sustainable Development Goals
COP26
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.